发明名称 6-(5-hydroxy-1H-pyrazol-1-yl)nicotinamide inhibitors of PHD
摘要 The present invention provides a method of treating acute heart failure by administering a compound of the formula:; or a pharmaceutically acceptable salt thereof.
申请公布号 US9345713(B2) 申请公布日期 2016.05.24
申请号 US201514693110 申请日期 2015.04.22
申请人 Takeda Pharmaceutical Company Limited 发明人 Brown Jason W.;Davis Melinda;Ivetac Anthony;Jones Benjamin;Kiryanov Andre A.;Kuehler Jon;Lanier Marion;Miura Joanne;Murphy Sean;Wang Xiaolun
分类号 A61K31/496;A61K31/551;A61K31/5513;C07D401/04;C07D401/14;C07D405/14;C07D413/14;C07D491/107;C07D417/14;C07D471/08;C07D487/06;C07D487/10;C07D491/10;A61K31/444;A61K31/4545;A61K31/4985;A61K31/5377 主分类号 A61K31/496
代理机构 代理人 Russo Matthew J.;Stemerick David M.
主权项 1. A method of treating acute heart failure, comprising administering to a patient in need thereof an effective amount of a compound of the formula or a pharmaceutically acceptable salt thereof, wherein q is 0, 1, or 2; s is 0, 1, or 2; R3, each time taken, is independently selected from the group consisting of hydrogen, hydroxyl, amino, C1-8 alkylamino, cyano, halo, C1-6 alkyl, and C1-4 alkoxy; R4 is selected from the group consisting of hydrogen, cyano, halo, methyl, ethyl, methoxy, and trifluoromethyl; R5 is selected from the group consisting of R6, each time taken, is independently selected from the group consisting of hydrogen, cyano, halo, C3-8 cycloalkyl, C1-6 alkyl, C1-4 alkoxy, and trifluoromethyl; R7 is selected from the group consisting of cyano and cyanomethyl; R8, each time taken, is independently selected from the group consisting of hydrogen, cyano, halo, C1-4 alkyl, C1-4 alkoxy, and trifluoromethyl; R9 is selected from the group consisting of hydrogen, C1-6 alkyl optionally substituted with 1 to 3 fluoro, and C3-8 cycloalkyl.
地址 Oksaka JP